Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial

Autor: Shimada, Kazuyuki *, Yamaguchi, Motoko, Atsuta, Yoshiko, Matsue, Kosei, Sato, Keijiro, Kusumoto, Shigeru, Nagai, Hirokazu, Takizawa, Jun, Fukuhara, Noriko, Nagafuji, Koji, Miyazaki, Kana, Ohtsuka, Eiichi, Okamoto, Masataka, Sugita, Yasumasa, Uchida, Toshiki, Kayukawa, Satoshi, Wake, Atsushi, Ennishi, Daisuke, Kondo, Yukio, Izumi, Tohru, Kin, Yoshihiro, Tsukasaki, Kunihiro, Hashimoto, Daigo, Yuge, Masaaki, Yanagisawa, Atsumi, Kuwatsuka, Yachiyo, Shimada, Satoko, Masaki, Yasufumi, Niitsu, Nozomi, Kiyoi, Hitoshi, Suzuki, Ritsuro, Tokunaga, Takashi, Nakamura, Shigeo, Kinoshita, Tomohiro
Zdroj: In The Lancet Oncology April 2020 21(4):593-602
Databáze: ScienceDirect